You may feel fine. Your standard laboratory tests indicate they are in the normal range. Then, out of the blue, you develop a chronic condition your physician says is associated with chronic low-grade inflammation, yet you had no pain. Your physician tells you that it had been building for a long time even though you couldn’t feel any pain. Somehow, you aren’t feeling very confident in the predictive value of modern medicine.

The New York Times recently published a long article on this type of inflammation (1). As the article points out, inflammation is a complex biological system that signals something is going wrong in the body. However, inflammation has two types. One type is acute pain (like a heart attack or asthma attack), but the more subtle type is chronic low-grade inflammation. This second type of inflammation is below the perception of pain. You might think of this type of inflammation as silent pain.

Thanks for reading Dr. Barry Sears Substack! Subscribe for free to receive new posts and support my work.

Subscribed

This type of inflammation results from prolonged immune cell activity without an immediate threat. If untreated, it can eventually develop into chronic metabolic inflammatory diseases in other organs. These conditions include diabetes, heart disease, autoimmune diseases, neurological diseases, among others.

Treating such silent pain inflammation with anti-inflammatory drugs may be counterproductive because those drugs potentially limit the body’s ability to respond to inflammation-causing threats from microbial invasions or physical injuries when they suddenly appear.

So, what is the answer? According to the New York Times article, no one seems to know.

I think we do.

Let me propose a potential unifying concept to explain the origin of this silent pain: increased cellular senescence.

What is cellular senescence?

Researchers first described it in the 1960s, when they noticed that cultured cells stop growing after a defined number of replications (2). Researchers initially thought it was an artifact of tissue culture techniques, but later recognized it was caused by molecular changes associated with aging. Specifically, cellular senescence is a response to internal cellular damage. The damaged cell stops growing and begins sending distress signals to the immune system to remove it (3).

What happens if a senescent cell is not removed?

Think of a senescent cell as a smoke detector with a dying battery. Rather than chirping, it sends inflammatory signals that it needs replacement. Your immune system acts as the maintenance crew, replacing the dying battery. If the damaged cell is not removed, it keeps sending inflammatory distress signals that can begin to damage nearby cells.

More ominously, those distress signals can circulate in the bloodstream and damage normal cells in other distant organs. This is a central driver of aging. That is why it is called inflammaging (4).

Eventually, this ongoing, chronic low-level inflammation leads to the development of chronic diseases later in life that require lifelong drug use to treat their symptoms. For some, it will be heart disease; for others, it might be diabetes, liver disease, cancer, neurological disease, and others. Although drugs can treat the symptoms, they don’t cure the underlying problem, which is the inability to remove or neutralize senescent cells.

How does the body remove senescent cells?

The key to removing senescent cells is a special group of immune cells called macrophages. These immune cells primarily kill or neutralize damaged cells, then digest them so the body can replace them with new, functional cells. Your metabolism ultimately controls both parts of this complex process.

How can you improve your metabolism to make it more effective in removing senescent cells?

The first step is making sure your metabolism (which includes your immune system) is working at peak efficiency to slow aging. The master switch of metabolism that controls aging is AMPK (5). The most powerful way to activate AMPK is calorie restriction.

This is also how GLP-1 drugs work: they decrease hunger, so you consume fewer calories, which activates AMPK, which slows the aging process. A recent study in individuals with HIV indicates that taking GLP-1 drugs slows down aging as determined by epigenetic clocks (6). Another metabolic benefit of AMPK activation is reducing the inflammatory signals produced by senescent cells (7).

The second obligatory step is to allow your immune cells, such as macrophages, natural killer cells, and T-cells, to destroy the damaged cell. This is why one medical expert quoted in the article stated, “When your immune system is losing its integrity, that’s when your age-related diseases crop up.”

For this second step to be successful, adequate intake of omega-3 fatty acids is required to produce hormones known as resolvins (8). This is why GLP-1 drugs are only partially successful in slowing aging. In animal models, completing this final stage of immunological clean-up of senescent cells requires increased resolvin production (9, 10).

Metabolic Engineering® provides a comprehensive system for neutralizing senescent cells by simultaneously increasing AMPK activity and resolvin production and decreasing oxidative stress, allowing your metabolism to prevent the spread of chronic low-grade inflammation to other cells.

Metabolic Engineering® has three dietary components that work together to help you keep senescent cells under control for a lifetime. Those three interacting dietary components are (a) the Zone diet, a calorie-restricted diet with a precise balance of protein, carbohydrates, and fat, (b) adequate levels of omega-3 fatty acids, and (c) sufficient levels of polyphenols to reduce oxidative stress. Each dietary component is good, but together they form your best defense against the buildup of senescent cells in your body.

What are the benefits of removing senescent cells?

The most obvious benefit is living longer and better by reducing inflammaging, the driving force behind chronic disease development (11).

How do you know if Metabolic Engineering® is working?

You can track reductions of chronic low-grade inflammation through several blood measures. One is related to AMPK activation and includes various markers of metabolic syndrome: excess body fat, an elevated triglyceride-to-HDL ratio, and high blood sugar.

Another measure reflects blood levels of omega-3 and omega-6 fatty acids, which control pro-inflammatory hormones called eicosanoids and the production of resolvins needed to allow macrophages to recognize and neutralize senescent cells.

How long will it take to start to slow down aging?

As soon as you start incorporating the concepts of Metabolic Engineering® into your diet, the most immediate physiological sign is suppressed appetite, indicating you are activating AMPK. Within 3-6 weeks, your blood markers will begin to improve as you start to reverse chronic low-grade inflammation induced by senescent cells.

References

1. Tingley K. The New Science of Inflammation. New York Times, July 29, 2026. https://www.nytimes.com/interactive/2026/07/29/magazine/inflammation-chronic-immune-system-health.html?searchResultPosition=1

2. Shay J, Wright, W. Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 1, 72–76 (2000). https://doi.org/10.1038/35036093

3. Di Micco R, Krizhanovsky V, Baker, D, d’Adda di Fagagna F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol 22: 75–95 (2021). doi.org/10.1038/s41580-020-00314-w

4. Zeidan RS , Shirali AS, Reinhard S, Picca A, Vial P, Pruinelli L, Garcia JGN , Leeuwenburgh C, Anton S. Inflammaging: From mechanisms to clinical implications and targeted interventions. Aging and Disease. 2026 doi.org/10.14336/AD.2025.1557

5. Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Research Reviews. 11;230-241 (2012) doi.org/10.1016/j.arr.2011.12.005.

6. Corley MJ, Dwaraka VB, Pang AP, Labbato D, Smith R, Ross Eckard A, McComsey GA. Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy. Nat Commun. 17:6606 (2026). doi: 10.1038/s41467-026-72861-3.

7. Liu M, Wei X, Zheng Z, Xie E, Yu Q, Gao Y, Ma J, Yang L. AMPK activation eliminates senescent cells in diabetic wound by inducing NCOA4-mediated ferritinophagy. Mol Med. 30:63 (2024). doi: 10.1186/s10020-024-00825-8.

8. Serhan CN, Levy BD. Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators. J Clin Invest. 128:2657-2669 (2018). doi: 10.1172/JCI97943.

9. Groenen AG, Lipscomb M, Bossardi Ramos R, Sadhu S, Bazioti V, Fredman G, Westerterp M. Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice. Prostaglandins Leukot Essent Fatty Acids. 202:102634 (2024). doi: 10.1016/j.plefa.2024.102634.

10. Lipscomb M, Salfate Del Rio I, Eid M, Rahtes A, Martino G, Sadhu S, Khan S, MacNamara KC, Fredman G. Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques. Vascul Pharmacol. 160:107527 (2025). doi: 10.1016/j.vph.2025.107527.

11. De Luca F, Camporeale V, Leccese G, Cuttano R, Troise D, Infante B, Stallone G, Netti GS, Ranieri E. From senescent cells to systemic inflammation: The role of inflammaging in age-related diseases and kidney dysfunction. Cells. 14(22):1831 (2025). doi: 10.3390/cells14221831.

Thanks for reading Dr. Barry Sears Substack! Subscribe for free to receive new posts and support my work.

Subscribed